Clinical‑grade stem cell and gene editing services to accelerate your translational pathway.
❯ For Cell Therapy Developers
Quality stem cells for high-impact research.
❯ For Stem Cell Researchers
Supporting your preclinical research goals from bench to bedside.
❯ For Diagnostic Developers
Human Tissue Samples
Genomic Services
From discovery to decision, human data that de-risks your drug pipeline.
❯ For Preclinical Drug Developers
One global partner for clinical logistics, processing, and data you can trust.
❯ For Clinical Drug Developers
Biospecimen Processing
Central Lab Services
Pharmacology-AI
Cells and products for stem cell research and 3D cell culture.
❯ All products
❯ Featured products
Our product catalog covers the territories of REPROCELL USA (Americas), REPROCELL Europe (EMEA), and Bioserve India.
Stem Cell Reagents
Cells
Stem Cell Products
3D Cell Culture
Labware
Upcoming Conferences
❯ Other events
Learning Center
Latest on our Blog
❯ More on the blog
REPROCELL Brands
Investor Relations
Past webinars hosted by REPROCELL. For upcoming webinars, see events.
Dr.-Ing. Patrick Bongartz and Dr. Marco OliveiraBioThrust
Dr Yongming Luke RenStem Cell Scientist, REPROCELL, Beltsville, MD
Dr. Luana FerrarQkine
Prof. Jaya Krishnan
On the REPROCELL blog
Latest
❯ More on our blog
From Biospecimen to Insight: How Human Tissue Improves Translational Confidence Bridging the Translational Gap in Drug Discovery
Explore how human tissue models enhance drug discovery by bridging the gap between preclinical findings and clinical success, improving translational confidence.
25 June 2026
Streamlining PBMC Processing for Reliable Results in Multi-Site Clinical Trials: Key Challenges and Solutions
Explore the challenges and solutions in PBMC processing for multi-site clinical trials, ensuring reliable results and data integrity for research success.
11 June 2026
AI-Designed CRISPR Enables Hypoimmune iPSC Engineering for Off-the-Shelf Cell Therapy
REPROCELL's StemEdit platform enables the creation of hypoimmune iPSCs for scalable off-the-shelf cell therapies, reducing immune rejection and enhancing patient access.
04 June 2026
What Are Off-Target Effects in Cellular Gene Editing? Risks, Detection, and Solutions
Explore off-target effects in gene editing, from CRISPR risks and AI-driven detection to genomic safety in iPSC therapies.
20 May 2026
Contact REPROCELL Global
Connect with our expert scientists and sales teams worldwide. We will figure out who's best to reply to you.
❯ Contact us other ways
US Sales Inquiries
UK/ Europe/ EMEA Sales Inquiries
India Sales Inquiries